Alison Slingsbury
Alison Slingsby is the Global Lead Women’s Health Innovation at Perrigo. Her main responsibilities are to uncover unmet needs and find appropriate new products and services to fill these gaps.
Alison’s career has been focused on Women’s Health for last 28 years, with her experience spanning across the various stages of a woman’s journey from contraception, fertility and through to menopause. Over her career Alison has been responsible for the launch of several new and innovative products.
At Perrigo we champion the right of women and people to determine their own sexual health journey and access the solutions they want. Alison is passionate to improve women’s lives through broadening access to solutions that really make a difference.
Alison is looking forward to networking and connecting with other like-minded professionals to continue on this journey.
Frederique Welgryn
Frederique Welgryn is a successful innovation centric executive with 20+ years of experience in Pharma & OTC. Passionate about healthcare and specifically Women's Health, Frederique has been involved or led major Rx-to-OTC programs and launches in Women’s Health in Europe or in the US in the last 10 years. Her team recently conducted the Rx-to-OTC switch of a Progestin Only Pill in the US, which received unanimous support from a joint FDA Advisory Committee Panel in May 2023.
In January 2023, she initiated the creation of a dedicated Global Women’s Health Division at Perrigo, with a mission to empower women and people to determine and access their own sexual health journey.
